Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 4367-4370, August 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walker, G. J.
Right arrow Articles by Cooksley, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walker, G. J.
Right arrow Articles by Cooksley, E.

Loss of Somatic Heterozygosity in Hepatocellular Carcinoma1

Graeme J. Walker, Nicholas K. Hayward2, Scott Falvey, W. Graham and E. Cooksley

Queensland Institute of Medical Research [G. W., N. H.] and the Clinical Research Centre of the Royal Brisbane Hospital Foundation and University of Queensland [W. G. E. C., S. F.], Herston, 4006, Australia

Loss of tumor suppressor genes is involved in the mechanism of tumorigenesis of many solid tumors. We tested 9 hepatitis B virus (HBV)-positive and 10 HBV-negative hepatocellular carcinomas for loss of somatic heterozygosity using 14 polymorphic probes mapping to chromosomes 4, 11, 13, and 17. Losses were found on all chromosome arms tested. The highest frequency of loss was observed at the D13S1 locus (67%) at band 13q12. Losses were also observed at three other loci on 13q. Twenty-one % of informative cases showed loss on 17p using the probe pYNZ22 which maps near the p53 locus. Losses on 4q were infrequent with 17% found at one locus and no loss at two others. The retinoblastoma gene and the locus on 17p were only inactivated in our HBV-negative tumors, although the numbers were too small for statistical significance. For all loci tested, we found no significant differences in the frequency of losses with HBV status, ethnic background, cirrhosis, grade of tumor, or presence of hemochromatosis.

1 This work was supported by a grant from the University of Queensland Special Project Grants Scheme.

2 To whom requests for reprints should be addressed, at Queensland Institute of Medical Research, Bramston Terrace, Herston, 4006, Australia.

Received 2/ 7/91. Accepted 6/10/91.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
N. Wong, P. Lai, E. Pang, L.-F. Fung, Z. Sheng, V. Wong, W. Wang, Y. Hayashi, E. Perlman, S. Yuna, et al.
Genomic Aberrations in Human Hepatocellular Carcinomas of Differing Etiologies
Clin. Cancer Res., October 1, 2000; 6(10): 4000 - 4009.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
L. M. Sargent, X. Zhou, C. L. Keck, N. D. Sanderson, D. B. Zimonjic, N. C. Popescu, and S. S. Thorgeirsson
Nonrandom Cytogenetic Alterations in Hepatocellular Carcinoma from Transgenic Mice Overexpressing c-Myc and Transforming Growth Factor-{alpha} in the Liver
Am. J. Pathol., April 1, 1999; 154(4): 1047 - 1055.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.